Rita de Cássia Lemos Lima

Rita de Cássia Lemos Lima

Auto-generated profile, based on publicly available information

Rita de Cássia Lemos Lima

Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
RLRita de Cássia Lemos Lima
Rita de Cássia Lemos Lima
FFFernanda Cristina Ferrari
Fernanda Cristina Ferrari
MSMaíra Ribeiro de Souza
Maíra Ribeiro de Souza
BPBruna Maria de Sá Pereira
Bruna Maria de Sá Pereira
CPCarmen Aparecida de Paula
Carmen Aparecida de Paula
DSDênia Antunes Saúde-Guimarães
Dênia Antunes Saúde-Guimarães

22 February 2019 in Food & Function
Verified
Journal Article
Closed access
PDF file
RLRita de Cássia Lemos Lima
Rita de Cássia Lemos Lima
RBRagnhild Stenberg Berg
Ragnhild Stenberg Berg
SRSissel Beate Rønning
Sissel Beate Rønning
NANils Kristian Afseth
Nils Kristian Afseth
SKSvein HAlvor Knutsen
Svein HAlvor Knutsen
SWSileshi G. Wubshet
Sileshi G. Wubshet
Inhibition of dipeptidyl peptidase IV (DPP-IV) and stimulation of muscle glucose uptake are two of the key strategies for management of type-2-diabetes (T2D). In the present study, four protein hydrolysates generated by enzymatic hydrolysis of chicken by-product, i.e., mechanical chicken deboning residue, were evaluated for their DPP-IV inhibitory activity as well as their effect on glucose uptake by skeletal muscle cells. The DPP-IV inhibitory assay was performed at two concentrations (1000 μg mL−1 and 10 μg mL−1) for the crude chicken protein hydrolysates. The hydrolysate with the highest DPP-IV inhibition was selected for preparative-scale fractionation using size-exclusion chromatography (SEC). The SEC fractions were tested for DPP-IV inhibitory activity as well as their effect on glucose uptake and metabolic activity of skeletal muscle cells. The muscle cells were treated with the SEC fractions and glucose uptake was measured based on luminescence detection of 2-deoxyglucose-6-phosphate (2DG6P). A fraction with peptides in the lower molecular weight range was shown to promote glucose uptake and to inhibit DPP-IV. Further chromatographic fractionation followed by inhibition assaying of the most potent SEC fraction led to isolation of five refined peptide fractions with more than 80% DPP-IV inhibition, which were subsequently analyzed with LC-HRMS/MS. This led to identification of 14 peptides as potential DPP-IV inhibitors from protein hydrolysates of mechanical chicken deboning residue.

1 March 2016 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
FFFernanda Cristina Ferrari
Fernanda Cristina Ferrari
RLRita de Cássia Lemos Lima
Rita de Cássia Lemos Lima
ZFZilma Schimith Ferraz Filha
Zilma Schimith Ferraz Filha
CBCamila Helena Barros
Camila Helena Barros
MAMarcela Carolina de Paula Michel Araújo
Marcela Carolina de Paula Michel Araújo
DSDênia Antunes Saúde-Guimarães
Dênia Antunes Saúde-Guimarães

1 March 2017 in Journal of Natural Products
Verified
Journal Article
Closed access
RLRita de Cássia L. Lima
Rita de Cássia L. Lima
SGSimone M. Gramsbergen
Simone M. Gramsbergen
JSJohannes Van Staden
Johannes Van Staden
AJAnna Jager
Anna Jager
Kenneth KongstadKenneth Kongstad
Kenneth Kongstad
Dan StaerkDan Staerk
Dan Staerk

17 July 2018 in Molecules
Verified
Journal Article
Open access
PDF file
RLRita De Cássia Lemos Lima
Rita De Cássia Lemos Lima
Kenneth KongstadKenneth Kongstad
Kenneth Kongstad
LKLucilia Kato
Lucilia Kato
MSMarcos José Da Silva
Marcos José Da Silva
HFHenrik Franzyk
Henrik Franzyk
Dan StaerkDan Staerk
Dan Staerk
Protein tyrosine phosphatase 1B (PTP1B) is an intracellular enzyme responsible for deactivation of the insulin receptor, and consequently acts as a negative regulator of insulin signal transduction. In recent years, PTP1B has become an important target for controlling insulin resistance and type 2 diabetes. In the present study, the ethyl acetate extract of leaves of Miconia albicans (IC50 = 4.92 µg/mL) was assessed by high-resolution PTP1B inhibition profiling combined with HPLC-HRMS-SPE-NMR for identification of antidiabetic compounds. This disclosed eleven PTP1B inhibitors, including five polyphenolics: 1-O-(E)-caffeoyl-4,6-di-O-galloyl-β-d-glucopyranose (2), myricetin 3-O-α-l-rhamnopyranoside (3), quercetin 3-O-(2″-galloyl)-α-l-rhamnopyranoside (5), mearnsetin 3-O-α-l-rhamnopyranoside (6), and kaempferol 3-O-α-l-arabinopyranoside (8) as well as eight triterpenoids: maslinic acid (13), 3-epi-sumaresinolic acid (14), sumaresinolic acid (15), 3-O-cis-p-coumaroyl maslinic acid (16), 3-O-trans-p-coumaroyl maslinic acid (17), 3-O-trans-p-coumaroyl 2α-hydroxydulcioic acid (18), oleanolic acid (19), and ursolic acid (20). These results support the use of M. albicans as a traditional medicine with antidiabetic properties and its potential as a source of PTP1B inhibitors.

1 August 2019 in Phytochemistry
Verified
Journal Article
Closed access
MPMalene J. Petersen
Malene J. Petersen
RLRita de Cássia Lemos Lima
Rita de Cássia Lemos Lima
LKLouise Kjaerulff
Louise Kjaerulff
Dan StaerkDan Staerk
Dan Staerk